Perioperative management of hilar cholangiocarcinoma
10.3760/cma.j.issn.1673-4203.2018.06.016
- VernacularTitle:肝门部胆管癌的围手术期处理
- Author:
Tianlong DING
1
;
Yanling MA
;
Dan WANG
;
Xiaolong LIU
;
Baohong GU
;
Xuemei LI
;
Yajing CHEN
;
Yumin LI
;
Hao CHEN
Author Information
1. 730030,兰州大学第二医院肿瘤外科
- Keywords:
Bile duct neoplasms;
Prognosis;
Perioperative care
- From:
International Journal of Surgery
2018;45(6):418-422,封4
- CountryChina
- Language:Chinese
-
Abstract:
Cholangiocarcinoma is a malignant tumor originating from bile duct epithelial cells, among which hilar cholangiocarcinoma is the most common, accounting for about 58%-70% of cholangiocarcinoma. Due to its atypical clinical features, special anatomical site, low radical resection rate, high recurrence rate and poor prognosis, the 5-year survival rate of hilar cholangiocarcinoma was only 14.7%-33.8%. Hence, the most effective method of hilar cholangiocarcinoma lies in early diagnosis and radical resection. Good perioperative management can improve the rate of radical resection of hilar cholangiocarcinoma and contribute a lot to prognosis of the patients. The perioperative management of hilar cholangiocarcinoma is described as follows.